Factors affecting outcome in resected EGFR-mutated lung cancer
Sign Up to like & getrecommendations! Published in 2022 at "Acta Oncologica"
DOI: 10.1080/0284186x.2022.2066984
Abstract: Abstract Introduction Long-term data on disease trajectory of EGFR-mutated early-stage non-small cell lung cancer (NSCLC) is still limited. This is relevant in the context of the recently approved introduction of adjuvant EGFR-targeting therapy, specifically osimertinib… read more here.
Keywords: lung cancer; lung; recurrence; egfr mutated ... See more keywords